Qilian International Holding Group (BGM) Competitors $11.19 +0.07 (+0.63%) Closing price 05/1/2025 03:58 PM EasternExtended Trading$10.97 -0.22 (-1.96%) As of 05:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock BGM vs. VRNA, PCVX, RYTM, PTCT, RNA, ZLAB, RARE, ACLX, OGN, and MRUSShould you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include Verona Pharma (VRNA), Vaxcyte (PCVX), Rhythm Pharmaceuticals (RYTM), PTC Therapeutics (PTCT), Avidity Biosciences (RNA), Zai Lab (ZLAB), Ultragenyx Pharmaceutical (RARE), Arcellx (ACLX), Organon & Co. (OGN), and Merus (MRUS). These companies are all part of the "pharmaceutical products" industry. Qilian International Holding Group vs. Verona Pharma Vaxcyte Rhythm Pharmaceuticals PTC Therapeutics Avidity Biosciences Zai Lab Ultragenyx Pharmaceutical Arcellx Organon & Co. Merus Qilian International Holding Group (NASDAQ:BGM) and Verona Pharma (NASDAQ:VRNA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings. Do analysts rate BGM or VRNA? Verona Pharma has a consensus target price of $81.50, indicating a potential upside of 12.79%. Given Verona Pharma's stronger consensus rating and higher probable upside, analysts plainly believe Verona Pharma is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Verona Pharma 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11 Does the media refer more to BGM or VRNA? In the previous week, Verona Pharma had 41 more articles in the media than Qilian International Holding Group. MarketBeat recorded 43 mentions for Verona Pharma and 2 mentions for Qilian International Holding Group. Verona Pharma's average media sentiment score of 1.07 beat Qilian International Holding Group's score of 0.93 indicating that Verona Pharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qilian International Holding Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Verona Pharma 18 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, BGM or VRNA? Qilian International Holding Group has higher earnings, but lower revenue than Verona Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M43.35-$1.44MN/AN/AVerona Pharma$42.28M138.13-$54.37M-$2.16-33.45 Which has more volatility & risk, BGM or VRNA? Qilian International Holding Group has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Verona Pharma has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Is BGM or VRNA more profitable? Qilian International Holding Group's return on equity of 0.00% beat Verona Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A Verona Pharma N/A -79.54%-43.49% Do institutionals and insiders believe in BGM or VRNA? 85.9% of Verona Pharma shares are held by institutional investors. 58.7% of Qilian International Holding Group shares are held by insiders. Comparatively, 4.8% of Verona Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor BGM or VRNA? Verona Pharma received 336 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/AVerona PharmaOutperform Votes33680.96% Underperform Votes7919.04% SummaryVerona Pharma beats Qilian International Holding Group on 10 of the 15 factors compared between the two stocks. Get Qilian International Holding Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.09B$6.84B$5.53B$7.93BDividend YieldN/A3.05%5.11%4.22%P/E RatioN/A7.3222.5118.54Price / Sales43.35241.49397.62103.30Price / CashN/A65.8538.1834.62Price / Book1.836.486.734.25Net Income-$1.44M$143.41M$3.22B$248.18M7 Day Performance-1.02%2.58%1.38%1.03%1 Month Performance1.08%5.00%2.79%2.70%1 Year PerformanceN/A-3.72%15.41%4.05% Qilian International Holding Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMQilian International Holding GroupN/A$11.19+0.6%N/AN/A$1.09B$25.10M0.00298VRNAVerona Pharma2.7155 of 5 stars$68.83+5.1%$78.50+14.0%+374.8%$4.36B$42.28M-35.8530Earnings ReportAnalyst ForecastInsider TradeShort Interest ↓Analyst RevisionNews CoveragePositive NewsPCVXVaxcyte2.9986 of 5 stars$32.90-0.1%$136.50+314.9%-44.7%$4.24BN/A-7.15160Upcoming EarningsPositive NewsRYTMRhythm Pharmaceuticals3.8167 of 5 stars$64.41+1.0%$74.92+16.3%+54.0%$4.07B$130.13M-14.88140Upcoming EarningsInsider TradePositive NewsPTCTPTC Therapeutics3.9769 of 5 stars$49.76+0.5%$63.92+28.5%+45.0%$3.92B$806.78M-8.381,410Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsRNAAvidity Biosciences2.8499 of 5 stars$31.20+1.2%$66.69+113.8%+26.7%$3.75B$10.90M-10.83190Upcoming EarningsPositive NewsZLABZai Lab2.1547 of 5 stars$32.43+1.3%$47.37+46.1%+95.9%$3.57B$398.99M-11.711,950Upcoming EarningsPositive NewsRAREUltragenyx Pharmaceutical4.3586 of 5 stars$37.98-0.3%$92.79+144.3%-10.0%$3.57B$560.23M-5.991,310Upcoming EarningsShort Interest ↑Positive NewsACLXArcellx1.8255 of 5 stars$64.55+1.3%$110.67+71.4%+25.6%$3.55B$107.94M-90.9180Upcoming EarningsPositive NewsOGNOrganon & Co.4.7169 of 5 stars$12.73+4.3%$19.75+55.1%-49.9%$3.28B$6.40B3.8210,000Earnings ReportOptions VolumeNews CoverageGap DownMRUSMerus3.4302 of 5 stars$45.28+3.9%$85.31+88.4%-3.3%$3.13B$36.13M-11.4637Upcoming EarningsShort Interest ↓Analyst RevisionNews CoveragePositive NewsGap Up Related Companies and Tools Related Companies VRNA Competitors PCVX Competitors RYTM Competitors PTCT Competitors RNA Competitors ZLAB Competitors RARE Competitors ACLX Competitors OGN Competitors MRUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qilian International Holding Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Qilian International Holding Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGM Stock Free BGM Stock Alerts